期刊文献+

低剂量与长期性激素替代疗法对绝经后妇女血脂水平的影响 被引量:3

Effect of low-dose long-term hormone replacement therapy on serum lipids in postmenopausal women
在线阅读 下载PDF
导出
摘要 目的探讨绝经后妇女低剂量与长期的性激素替代疗法(HRT)对血脂水平的影响.方法研究对象为北京协和医院女职工141人,年龄50~87岁、平均68岁,其中绝经后低剂量HRT 5~31年63人为HRT组.以年龄匹配78人为对照组.空腹12~14 h取静脉血,分离血清,检测血脂、脂蛋白和载脂蛋白等九项指标.结果HRT组与对照组比较:甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白AⅠ(ApoAⅠ)、脂蛋白(a)[Lp(a)]两组之间差异无统计学意义;总胆固醇(TC)、TC/HDL-C、载脂蛋白E(ApoE)、载脂蛋白CⅢ(ApoCⅢ)和载脂蛋白B(ApoB)差异有统计学意义. 结论绝经后妇女经低剂量与长期的HRT可使TC、ApoB、ApoCⅢ、ApoE、TC/HDL-C水平明显下降.血脂水平的下降对心血管系统有保护作用,并可降低心血管事件发生和发展的危险性. Objective: To study the effects of low-dose blood lipids in postmenopausal women. and long-term hormone replacement therapy (HRT) on Methods: A total of 141 postmenopausal female medical staff (aged 50 to 87 years, average 68 years) from Peking Union Medical College Hospital were recruited. Among them, 63 received low-dose HRT for 5~31 years were taken as HRT group, and other 78 age-matched postmenopausal women as the control group. Vein blood was taken from the women fasting for 12~14 h and the serum isolated for the determination of serum concentrations of lipid, lipoprotein and apolipoprotein. Data were analyzed with SPSS statistical software and the statistical significance was considered to be P〈0.05. Results: In comparison with the controls, the levels of TG, HDL-C, LDL-C, ApoA, Lp(a) in the women of HRT group had no significant difference, but those of TC, TC/HDL-C, ApoE, ApoCⅢ and ApoB significantly decreased. Conclusions: The serum levels of TC, LDL-C, ApoB, ApoCⅢ, ApoE decrease obviously in the postmenopausal women receiving low-dose and long-term HRT. The decrease of blood lipid levels may protect cardiovascular system and reduce the risk of cardiovascular events.
出处 《生殖医学杂志》 CAS 2006年第3期157-160,共4页 Journal of Reproductive Medicine
基金 科技部1999年度攀登-特别支持费资助(国科基字[1999]045)
关键词 血脂 激素替代疗法 绝经后妇女 Lipid Hormone replacement therapy Postmenopausal women
  • 相关文献

参考文献6

  • 1Christodoulakos GE,Lambrinoudaki Ⅳ,Panoulis CP.Effect of hormone replacement therapy,tibolone and raloxifene on serum lipids,apolipoprotein A1,apolipoprotein B and lipoprotein(a) in Greek[J].Gyn Endocrinol,2004,18(5):244-257.
  • 2孙梅励,聂敏,何方方,葛秦生.短期与长期激素替代疗法对绝经后妇女血脂的影响[J].生殖医学杂志,2004,13(3):131-134. 被引量:6
  • 3聂敏,孙梅励,宋爱羚,葛秦生.长期小剂量性激素疗法对绝经后妇女血压及血管活性因子的作用[J].生殖医学杂志,2005,14(6):321-324. 被引量:2
  • 4Michael E.Mendelsohn MD.Protective effects of estrogen on the cardiovaschlar system[J].AM J Cardiol,2002,89[Suppl]:12E-18E.
  • 5Lobo RA,Bush T,Carr BR,et al.Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins,coagulation factors,and carbohydrate metabolism[J].Fertil Steril,2001,76(1):13-24.
  • 6The Writing group for the PEPI Trial.Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women.The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial[J].JAMA,1995,73(3):199-208.

二级参考文献22

  • 1Ossewaarde ME,Dallinga Thie GM,Bots ML,et al. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women : results from a randomized trial [J]. Eur J Clin Invest, 2003,33 (5):376-382.
  • 2Writing group for the women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial [J]. J Am Med Assoc, 2002, 288(3)
  • 3Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence [J]. Am J Cardiol, 2002, 90 (1A): 22F-25F.
  • 4Schneider HPG. The view of the international menopause society on the Women's Health Initiative[J]. Climacteric, 2002, 5(3): 211-216.
  • 5Knopp RH. Risk factors for coronary artery disease in women [J]. Am J Cardiol, 2002, 89[Suppl]: 28E-35E.
  • 6Kuller LH. Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative [J]. Arterioscler Thromb Vasc Biol, 2003, 23(1):11-16.
  • 7Mendelsohn ME. Protective effects of estrogen on the cardiovascular system [J]. Am J Cardiol, 2002, 89[Suppl]: 12E-18E.
  • 8Humphries Kh,Gill S .Risks and benefits of hormone re- placement therapy : the evidence speaks [J].CMAJ, 2003,168 (8) :1001-1010.
  • 9Mikkola TS,Clarkson TB.Estrogen replacement therapy,atherosclerosis,and vascular function [J].Cardiovascular Research,2002,53 (3):605-619.
  • 10Endemann DH,Schiffrin EL.Endothelial dysfunction[J].J Am Soc Nephrol,2004,15(8) :1983-1992.

共引文献6

同被引文献46

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部